Skip to main content
Caplight Logo









IDE Group

IDE Group

Private
SydneyHealthcare & Life Scienceshttps://ide.group

Last Round

Grant

Jun 20, 2025

Total Funding Raised

$1.11M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

IDE Group operates in Healthcare & Life Sciences and is based in Sydney. Its latest recorded funding round was a Grant round in June 2025.

IDE Group is a medical technology product development and commercialization partner that provides engineering, design, and regulatory services to healthcare companies and startups.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Compliance, Biotech Equipment, Quality Management

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

IDE Group Comparables

Compare IDE Group with similar companies based on industry and business-model similarity.

IDE Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Team Consulting
88%
Planet Innovation
88%
CLEIO
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

IDE Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 20, 2025
GrantJan 20, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

IDE Group Investors

Notable investors and investment history

IDE Group investors
InvestorRounds
AUScelerateGrant
Provincie Zuid-HollandGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 13, 2026

    Monthly visitors grew 94% MoM, reaching 12.1K.

  • Jun 20, 2025

    $780K grant round led by AUScelerate.

Book a demo to see all signals

For institutional investors. Book with your work email.

IDE Group Filings

Explore SEC and related filing metadata, where available.

IDE Group filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about IDE Group's valuation, stock price, and market status.

Is IDE Group a public or private company?

IDE Group is a private company.

What is the current stock price of IDE Group?

IDE Group is a private company, so its shares have no public market price. Caplight tracks IDE Group's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is IDE Group worth (valuation)?

Valuation information for IDE Group is not publicly available.

Can I buy IDE Group stock?

IDE Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was IDE Group's last funding round?

IDE Group's most recent funding round was Grant on June 20, 2025.

Who are the main investors in IDE Group?

Key investors in IDE Group include AUScelerate, Provincie Zuid-Holland.

Will IDE Group IPO soon?

No public IPO plans have been announced for IDE Group.

How can I track IDE Group secondary market activity?

Caplight tracks bids, offers, and trades in IDE Group's shares on secondary markets.

Firmographic Details

HeadquartersSydney
Employee Range78
Year Founded2003
Last FundingJun 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?